Objectives: 

  1. Discuss new evidence related to perioperative bladder therapy options
  2. Summarize new evidence related to perioperative prostate cancer and describe evidence in support of it
  3. Summarize the clinical efficacy of daraxonrasib in pancreatic cancer
  4. Explain the clinical toxicity and tolerance of daraxonrasib
  5. Identify the resistance mechanisms to multi-selective RAS inhibition

Zoom:

Join from PC, Mac, iPad, or Android:

https://uwmadison.zoom.us/s/96439227117?pwd=VBYKNo46Bole5Gqbyq0aDhFU4aKbN3.1; Passcode:043571

Phone one-tap: +13126266799,,96439227117# US (Chicago); +16469313860,,96439227117# US

Join via audio: +1 312 626 6799 US (Chicago); +1 646 931 3860 US; +1 929 205 6099 US (New York); +1 301 715 8592 US (Washington DC); +1 305 224 1968 US; +1 309 205 3325 US; +1 689 278 1000 US; +1 719 359 4580 US; +1 253 205 0468 US; +1 253 215 8782 US (Tacoma); +1 346 248 7799 US (Houston); +1 360 209 5623 US; +1 386 347 5053 US; +1 507 473 4847 US; +1 564 217 2000 US; +1 669 444 9171 US; +1 669 900 6833 US (San Jose); Webinar ID: 964 3922 7117

International numbers available: https://uwmadison.zoom.us/u/aeJ5RZVb8P

Join from an H.323/SIP room system: H.323: 144.195.19.161 (US West) or 206.247.11.121 (US East) Meeting ID: 964 3922 7117; Passcode: 043571

SIP: [email protected]; Passcode: 043571

Session date: 
09/02/2026 - 8:00am to 9:00am CDT
Location: 
In-person and Virtually
600 Highland Avenue (CSC)
G5/119
Madison, WI 53705
United States
See map: Google Maps
  • 1.00 AAPA Category 1 CME
  • 1.00 ACPE Contact Hours - Pharmacist
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC Contact Hours
  • 1.00 University of Wisconsin–Madison Continuing Education Hours
    • 1.00 Approved for AMA PRA Category 1 Credit™
Add to calendar: 
Please login or register to take this course.
Discloser List CME Internal Report
Presenter(s): 
Dr. Anthony Serritella
Dr. Jeremy Kratz